Key Details
Last Dividend
$1801.73Annual ROE
-7.06%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 16, 2023Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
May 12, 1980Next split:
N/ARecent split:
June 07, 2022Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with AIKI included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of AIkido Pharma?
- What is the ticker symbol for AIkido Pharma?
- Does AIkido Pharma pay dividends?
- What sector is AIkido Pharma in?
- What industry is AIkido Pharma in?
- What country is AIkido Pharma based in?
- When did AIkido Pharma go public?
- Is AIkido Pharma in the S&P 500?
- Is AIkido Pharma in the NASDAQ 100?
- Is AIkido Pharma in the Dow Jones?
- When was AIkido Pharma's last earnings report?
- When does AIkido Pharma report earnings?
What is the primary business of AIkido Pharma?
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.
What is the ticker symbol for AIkido Pharma?
The ticker symbol for AIkido Pharma is NASDAQ:AIKI
Does AIkido Pharma pay dividends?
No, AIkido Pharma does not pay dividends
What sector is AIkido Pharma in?
AIkido Pharma is in the Healthcare sector
What industry is AIkido Pharma in?
AIkido Pharma is in the Biotechnology industry
What country is AIkido Pharma based in?
AIkido Pharma is headquartered in United States
When did AIkido Pharma go public?
AIkido Pharma's initial public offering (IPO) was on 18 March 1980
Is AIkido Pharma in the S&P 500?
No, AIkido Pharma is not included in the S&P 500 index
Is AIkido Pharma in the NASDAQ 100?
No, AIkido Pharma is not included in the NASDAQ 100 index
Is AIkido Pharma in the Dow Jones?
No, AIkido Pharma is not included in the Dow Jones index
When was AIkido Pharma's last earnings report?
AIkido Pharma's most recent earnings report was on 16 May 2023
When does AIkido Pharma report earnings?
The date for AIkido Pharma's next earnings report has not been announced yet